Your browser doesn't support javascript.
loading
Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors.
Chawla, Neal S; Sayegh, Nicolas; Tripathi, Nishita; Govindarajan, Ameish; Zengin, Zeynep B; Phillip, Errol J; Dizman, Nazli; Meza, Luis; Muddasani, Ramya; Chehrazi-Raffle, Alexander; Malhotra, Jasnoor; Hsu, JoAnn; Agarwal, Neeraj; Pal, Sumanta K; Tripathi, Abhishek.
Affiliation
  • Chawla NS; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Sayegh N; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Tripathi N; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Govindarajan A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Zengin ZB; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Phillip EJ; School of Medicine, University of California San Francisco, San Francisco, CA.
  • Dizman N; Yale University School of Medicine, New Haven, CT.
  • Meza L; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Muddasani R; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Chehrazi-Raffle A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Malhotra J; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Hsu J; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Agarwal N; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.
  • Pal SK; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA.
  • Tripathi A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA. Electronic address: atripathi@coh.org.
Clin Genitourin Cancer ; 21(1): 69-75, 2023 02.
Article in En | MEDLINE | ID: mdl-36509613
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Carcinoma, Transitional Cell Type of study: Prognostic_studies / Risk_factors_studies Limits: Female / Humans Language: En Journal: Clin Genitourin Cancer Journal subject: NEOPLASIAS / UROLOGIA Year: 2023 Document type: Article Affiliation country: Country of publication: